Nigel Mackman,
Distinguished Professor of Medicine
Dr. Mackman began his scientific career studying the role of Escherichia coli hemolysin toxin in bacterial pathogenesis. He received a PhD from the University of Leicester. In 1987 he moved to The Scripps Research Institute in California as a postdoctoral fellow to study blood coagulation and rose to the rank of Associate Professor with tenure. In 2007, Dr. Mackman moved to the University of North Carolina at Chapel Hill to become the John C. Parker Distinguished Professor in Medicine. His research has focused on the roles of tissue factor, coagulation proteases, protease activated receptors, extracellular vesicles, thrombosis, inflammation, ischemia-reperfusion injury, cancer, sickle cell disease, obesity, viral infection and atherosclerosis. In 2009 he presented the Sol Sherry Lecture on Thrombosis. He has chaired the Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Council of the American Heart Association, and in 2010 chaired the Hemostasis Gordon Research Conference. In 2015 he received a Distinguished Scientist Award from the International Society of Thrombosis and Hemostasis. Dr. Mackman has served as an Associate Editor for Thrombosis & Hemostasis and the Journal of Thrombosis and Hemostasis, and is currently an Associate Editor for the Journal of Clinical Investigation and a Senior Associate Editor for ATVB. In 2017 he received an ATVB Distinguished Achievement Award.
|
|
|
